This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. By taking a more proactive—rather than reactive—approach to research, organizations can leverage better-informed strategies to stay ahead of their competitors.
Within the ever-evolving realm of the life sciences industry , fast-paced healthcare investment research plays a crucial role in providing timely insights on valuable opportunities for financial investors.
Our all-in-one market intelligence platform allows users to streamline their primaryresearch workflows with on-demand access to our expert transcript library and Expert Call Services. One common misconception is the view that expert perspectives may introduce a potential risk for bias in the research process.
Industry nuances, company culture, leadership styles, competitor interactions—these are facets you can’t necessarily uncover by researching numbers and figures, yet they significantly impact whether or not two companies have the right synergies to succeed. Navigating the cultural challenges around M&A integration is a delicate process.
Expert interviews are a critical primaryresearch tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. Soft Data – Investment researchers often use soft market data to add qualitative context to numerical data and create a comprehensive view of any research topic.
These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their market research, landscaping, and monitoring. Some are equipped with artificial intelligence capabilities that enable you to maximize and streamline your research, while others are more traditional in their approach.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content